Dyspnea, or shortness of breath, is a common symptom encountered in medical practice. Its underlying causes are diverse, making it a challenging symptom to manage. This article aims to provide a comprehensive approach to dyspnea, aiding healthcare professionals in its effective diagnosis and management.
Dyspnea is a subjective experience, often described as an uncomfortable awareness of breathing. It can be caused by cardiac, pulmonary, metabolic, or psychological conditions. Understanding the pathophysiological mechanisms behind dyspnea is crucial in identifying its cause.
A thorough history and physical examination are pivotal in the evaluation of dyspnea. Assessing the onset, duration, severity, and associated symptoms can provide valuable clues. Physical examination should focus on the cardiovascular and respiratory systems, but should also include other systems based on the patient's history.
Initial investigations should include a complete blood count, chest X-ray, and electrocardiogram. Depending on the clinical suspicion, further investigations such as pulmonary function tests, echocardiogram, or computed tomography scan may be warranted. The goal is to identify the underlying cause and guide management.
Management of dyspnea is tailored to the underlying cause. This may range from medication for conditions such as asthma or heart failure, to non-pharmacological measures like pulmonary rehabilitation or cognitive-behavioral therapy. Patient education and reassurance are essential components of management.
Dyspnea is a complex symptom requiring a comprehensive clinical approach for effective management. By understanding its underlying mechanisms, conducting a thorough assessment, and tailoring management to the identified cause, healthcare professionals can significantly improve patient outcomes.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation